Ginsenoside Re enhances survival of human CD4+ T cells through regulation of autophagy
Authors:
- 1 May 2010
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 10 (5) , 626-631
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ginsenoside Rp1, a Ginsenoside Derivative, Blocks Lipopolysaccharide-Induced Interleukin-1β Production via Suppression of the NF-κB PathwayPlanta Medica, 2009
- Botanical characteristics, pharmacological effects and medicinal components of KoreanPanax ginsengC A MeyerActa Pharmacologica Sinica, 2008
- Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyteBiochemical and Biophysical Research Communications, 2007
- Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in miceVaccine, 2007
- Ginsenoside Rd from Panax notoginseng Is Cytotoxic towards HeLa Cancer Cells and Induces ApoptosisChemistry & Biodiversity, 2006
- Radioprotective potential of ginsengMutagenesis, 2005
- Ginsenoside Rg1 enhances CD4+ T-cell activities and modulates Th1/Th2 differentiationInternational Immunopharmacology, 2004
- Antiallergic Activity of Ginsenoside Rh2Biological and Pharmaceutical Bulletin, 2003
- Ginsenosides from Panax ginseng Differentially Regulate Lymphocyte ProliferationPlanta Medica, 2002
- Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 proteaseBiochemical Pharmacology, 2000